MassIVE MSV000091619

Partial Public

Effect of Kinase Inhibitors on Intraerythrocytic Plasmodium falciparum Phosphoproteome

Subscribe Comment Convert Spectra Add Reanalysis

Description

Three flasks of asynchronous blood stage P. falciparum Dd2 culture were grown to ~15% parasitemia, 4% hematocrit using the Trager- Jensen method. Per biological replicate, parasites were treated with 5 x EC50 or EC90 of compound depending on the slope of the EC50 curve for 3 hours. Compounds are DC-12717, DC-12834, BI-2536, GSK461364, and DC-12862. All compounds have three biological replicates, except DC-12862 which has one. As a control, culture was treated with an equal volume of DMSO vehicle. Parasites were collected through saponin lysis of erythrocytes, and parasite pellets were resuspended in 8 M urea lysis buffer (8 M urea, 50 mM Tris pH 8.5, 1% SDS), supplemented with a protease and phosphatase inhibitor cocktail. Parasites were lysed by sonication, and protein was quantified with the BCA protein assay. Samples were reduced, alkylated, resuspended, and digested. Resulting peptides were quantified and labelled with isobaric tandem mass tags (TMT). Following a ratio check, phospho-enrichment was performed with a Pierce High-Select Fe-NTA Phosphopeptide Enrichment Kit. The resultant phosphopeptide eluate was analyzed with LC-MS2. The peptide flowthrough was fractionated by basic reverse phase HPLC and similarly analyzed with LC-MS3. Spectra were searched against a composite P. falciparum and human Uniprot database (https://www.uniprot.org/), using the COMET algorithm. Peptide matches were filtered with a 1% false discovery rate (FDR), and peptides with a summed signal-to-noise (SN) threshold of >100 were quantified. For phosphopeptides, a 1% FDR filter was used, and a summed SN threshold of greater than or equal to 100. Channels: 126 - Culture 1 Control, 127N - Culture 2 Control, 127C - Culture 3 Control, 128N - Culture 1 DC-12717 128C - Culture 2 DC-12717 129N - Culture 3 DC-12717, 129C - Culture 1 DC-12835, 130N - Culture 2 DC-12835, 130C - Culture 3 DC-12835, 131N - Culture 1 BI-2536, 131C - Culture 2 BI-2536, 132N - Culture 3 BI-2536, 132C - Culture 1 GSK461364, 133N - Culture 2 GSK461364, 133C - Culture 3 GSK461364, 134N - Culture 1 DC-12862 [doi:10.25345/C56W96K4S] [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: plasmodium ; malaria ; kinase ; inhibitor ; erythrocyte

Contact

Principal Investigators:
(in alphabetical order) 		Debopam Chakrabarti, University of Central Florida, USA
Submitting User: mbohmer

Publications

Bohmer MJ, Wang J, Istvan ES, Luth MR, Collins JE, Huttlin EL, Wang L, Mittal N, Hao M, Kwiatkowski NP, Gygi SP, Chakrabarti R, Deng X, Goldberg DE, Winzeler EA, Gray NS, Chakrabarti D.
Human Polo-like Kinase Inhibitors as Antiplasmodials.
ACS Infect Dis. Epub 2023 Mar 15.

Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
 
FTP Download Link (click to copy):

Species

Instrument

Modifications

- Dataset Reanalyses

+ Dataset History

Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.